Updated Florida Medical Marijuana Course for MMTC Medical Directors

Posted in Latest News on January 16, 2018.

On January 3, 2018, the Florida Medical Association and Florida Osteopathic Medical Association issued an updated 2-credit course titled Florida Medical Marijuana Course for MMTC Medical Directors. This course addresses the current laws and rules that govern Medical Directors for Florida Medical Marijuana Treatment Centers (MMTCs). Allopathic and Osteopathic physicians who choose to serve in this capacity are required to complete this course and pass the post-test during each licensure term.

If your license is up for renewal on January 31, 2018, you will need to complete the updated course by that date. If you wait until after your renewal date, you will be out of compliance with Florida law. Already qualified Medical Directors who met the education requirement before January 3, 2018, must also successfully complete this course no later than your next renewal cycle to maintain compliance with Florida law as a Medical Director.

What should you do if you plan to continue to be a Medical Director for a Florida MMTC:

  1. Take the Florida Medical Marijuana Course for MMTC Medical Directors as soon as possible. Please visit https://flmedical.inreachce.com/ to sign up for the course.
  2. Self-report the completion of the course to CEBroker at https://www.cebroker.com/to avoid a lapse in your access to the registry.


More Latest News

Temporary Changes to CE Requirements (COVID-19)
March 13, 2020

Today, the Florida Board of Osteopathic Medicine entered into emergency rulemaking and adopted Rule 64B15ER20-18, which waives the requirement for live, participatory attendance for certain continuing education courses for the 2018-2020 biennium, in accordance with Executive Orders 20-51 and 20-52 declaring a public health emergency pursuant to the spread of the Coronavirus Disease 2019 (COVID-19). Continue reading


New Coronavirus: COVID-19
February 17, 2020

The Florida Department of Health (Department) is working closely with the Centers for Disease Control and Prevention (CDC) to closely monitor the current outbreak of 2019 novel coronavirus. Continue reading